CoreRx Pharmaceuticals specializes in providing comprehensive contract development and manufacturing organization (CDMO) services, focusing on drug development and manufacturing solutions. Their expertise encompasses a wide range of pharmaceutical services, including pre-formulation, formulation, analytical testing, and both clinical and commercial scale manufacturing. CoreRx is recognized for its ability to handle various dosage forms, such as solid oral, liquid oral, and semi-solid formulations. The company emphasizes speed to clinic and market, ensuring that drug products are developed and launched efficiently while maintaining high-quality standards throughout the process.

In addition to their core services, CoreRx is committed to delivering customized solutions tailored to the unique needs of their partners. They employ a team of experienced scientists and pharmaceutical professionals who utilize innovative problem-solving techniques to address complex formulation challenges. The recent expansion of Bend Bioscience, a partner organization, highlights CoreRx's dedication to enhancing their capabilities, with the opening of a state-of-the-art Pharmaceutical Process and Manufacturing Science Facility designed to meet Good Manufacturing Practice (GMP) standards. This facility is equipped with advanced processing suites and technologies that support the development and production of high-quality materials for clinical trials, further solidifying CoreRx's position as a leader in the CDMO industry.

United States

CoreRx, Inc. is an industry leading Contract Development and Manufacturing Organization (CDMO), providing innovative drug formulation development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. With its state-of-the-art, multi-site campus in Clearwater, Florida, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale and across a range of dosage forms.

CoreRx Pharmaceuticals

Company Details